Growth Metrics

Xeris Biopharma Holdings (XERS) Capital Expenditures (2020 - 2021)

Xeris Biopharma Holdings (XERS) has disclosed Capital Expenditures for 2 consecutive years, with $131000.0 as the latest value for Q4 2021.